You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors

 

Online download statistics by month:

Online download statistics by month: January 2022 to January 2026

AbstractFullPdf
Jan 2022598629313
Feb 2022480497166
Mar 202225426894
Apr 2022324342101
May 2022331350180
Jun 202230231790
Jul 202232132995
Aug 202230331595
Sep 2022267273118
Oct 2022371385104
Nov 202224324365
Dec 202221121657
Jan 202317718038
Feb 202323924070
Mar 202318819090
Apr 202319319660
May 202315415570
Jun 202315215750
Jul 202313313860
Aug 202315215663
Sep 202310811040
Oct 202310210232
Nov 202311011226
Dec 202310911037
Jan 202413213272
Feb 202411912155
Mar 202415116268
Apr 202416016254
May 202413513645
Jun 202412412462
Jul 202413313443
Aug 2024119118191
Sep 202412812847
Oct 202412512655
Nov 202413613766
Dec 202416516952
Jan 202518518549
Feb 202513914043
Mar 202515015064
Apr 202514814978
May 202514914960
Jun 202511111229
Jul 2025110
Nov 2025550
Jan 2026001
Total833785503248